(S (NP (NP (DT The) (NN level)) (PP (IN of) (NP (NP (NML (NN PD) (HYPH -) (NN L1)) (NN expression)) (PP (IN in) (NP (NML (NN immunohistochemistry) (-LRB- -LRB-) (NN IHC) (-RRB- -RRB-)) (NNS assays)))))) (VP (VBZ is) (NP (NP (NP (DT a) (JJ key) (NN biomarker)) (PP (IN for) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NML (NNP Non-Small-Cell-Lung-Cancer) (-LRB- -LRB-) (NNP NSCLC) (-RRB- -RRB-)) (NNS patients)))))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB respond) (PP (IN to) (NP (ADJP (AFX anti) (NN PD)) (NML (PP (HYPH -) (NP (CD 1))) (HYPH /) (NP (NN PD) (HYPH -) (NN L1))) (NNS treatments))))))))) (. .))
(S (NP (NP (DT The) (NN quantification)) (PP (IN of) (NP (NML (NN PD) (HYPH -) (NN L1)) (NN expression)))) (ADVP (RB currently)) (VP (VP (VBZ includes) (NP (NP (DT the) (JJ visual) (NN estimation)) (PP (IN of) (NP (DT a) (NNP Tumor) (NML (NN Cell) (PRN (-LRB- -LRB-) (NP (NN TC)) (-RRB- -RRB-))) (NN score)))) (PP (IN by) (NP (DT a) (NN pathologist)))) (CC and) (VP (VBZ consists) (PP (IN of) (S (VP (VBG evaluating) (NP (NP (DT the) (NN ratio)) (PP (IN of) (NP (ADJP (ADJP (NP (NN PD) (HYPH -) (NN L1)) (JJ positive)) (CC and) (ADJP (NP (NN PD) (HYPH -) (NN L1)) (JJ negative))) (NN tumor) (NNS cells))))))))) (. .))
(S (NP (NP (JJ Known) (NNS challenges)) (PP (IN like) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (NP (NN positivity) (NN estimation)) (PP (IN around) (NP (ADJP (RB clinically) (JJ relevant)) (NN cut) (HYPH -) (NNS offs)))) (CC and) (NP (NP (JJ sub-optimal) (NN quality)) (PP (IN of) (NP (NNS samples))))))))) (VP (VBZ makes) (NP (NP (JJ visual) (NN scoring)) (ADJP (JJ tedious) (CC and) (JJ subjective))) (, ,) (S (VP (VBG yielding) (NP (NP (DT a) (NN scoring) (NN variability)) (PP (IN between) (NP (NNS pathologists))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (NML (JJ deep) (NN learning)) (NN solution)) (SBAR (WHNP (WDT that)) (S (VP (VBZ enables) (NP (NP (DT the) (JJ first) (VBN automated)) (CC and) (NP (NP (JJ objective) (NN scoring)) (PP (IN of) (NP (NP (NML (NN PD) (HYPH -) (NN L1)) (NN expression)) (PP (IN in) (NP (NML (JJ late) (NN stage)) (NN NSCLC) (NN needle) (NNS biopsies)))))))))))) (. .))
(S (S (VP (VP (TO To) (VP (VB account) (PP (IN for) (NP (NP (DT the) (JJ low) (NN amount)) (PP (IN of) (NP (ADJP (ADJP (NN tissue) (JJ available)) (PP (IN in) (NP (NN biopsy)))) (NNS images))))))) (CC and) (VP (TO to) (VP (VB restrict) (S (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (JJ manual) (NNS annotations)))) (ADJP (JJ necessary) (PP (IN for) (NP (NN training))))))))) (, ,) (NP (PRP we)) (VP (VBP explore) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ semi-supervised) (NNS approaches)) (PP (IN against) (NP (JJ standard) (ADJP (RB fully) (JJ supervised)) (NNS methods))))))) (. .))
(S (NP (PRP We)) (VP (VBP consolidate) (NP (NP (NP (DT the) (NML (JJ manual) (NNS annotations))) (VP (VBN used) (PP (IN for) (NP (NN training))))) (CONJP (RB as) (RB well)) (NP (NP (DT the) (JJ visual) (NN TC) (NNS scores)) (VP (VBN used) (PP (IN for) (NP (JJ quantitative) (NN evaluation))) (PP (IN with) (NP (JJ multiple) (NNS pathologists))))))) (. .))
(S (NP (NP (NN Concordance) (NNS measures)) (VP (VBN computed) (PP (IN on) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (NNS slides)) (ADJP (JJ unseen) (PP (IN during) (NP (NN training)))))))))) (VP (VBP provide) (NP (NN evidence)) (SBAR (IN that) (S (NP (PRP$ our) (JJ automatic) (NN scoring) (NN method)) (VP (VBZ matches) (NP (JJ visual) (NN scoring)) (PP (IN on) (NP (DT the) (VBN considered) (NN dataset))) (SBAR (IN while) (S (VP (VBG ensuring) (NP (NN repeatability) (CC and) (NN objectivity))))))))) (. .))
